Close Menu

NEW YORK – Quanterix said on Thursday that it has priced a public offering of 3,571,428 shares of its common stock at $70.00 per share. The Billerica, Massachusetts-based firm expects gross proceeds of around $250 million from the offering, which it announced on Wednesday.

The company has granted the underwriters a 30-day option to purchase up to an additional 535,714 shares of common stock at the public offering price less underwriting discounts, commissions, and offering expenses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.